Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 5, 2017

Primary Completion Date

July 30, 2017

Study Completion Date

September 30, 2017

Conditions
Urinary Tract Infections
Interventions
COMBINATION_PRODUCT

Lactobacillus reuteri

Sachet one contains a total of 5\*10\^8 CFU of Lactobacillus reuteri DSM 16666 \& Lactobacillus reuteri DSM 17938, mixed with maltodextrin for flowability during production. Sachet two contains instant cranberry drink composed of Cranberry extract, xylitol, cranberry aroma, monosodium citrate, zink gluconate, silica. The products will be taken twice per day, morning and evening. The daily dose in the active group will be at least 5\*10\^8 CFU of L.reuteri DSM16666 and L. reuteri DSM17938), PAC-A and zinc

DIETARY_SUPPLEMENT

Sachet with cranberry + placebo

Sachet one contains placebo for probiotics (maltodextrin). Sachet two contains instant cranberry drink composed of Cranberry extract, xylitol, cranberry aroma, monosodium citrate, zink gluconate, silica.

Trial Locations (1)

14080

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

All Listed Sponsors
lead

Innovacion y Desarrollo de Estrategias en Salud

OTHER

NCT03019172 - Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women | Biotech Hunter | Biotech Hunter